Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials

Clin Transl Oncol. 2023 Mar;25(3):578-591. doi: 10.1007/s12094-022-02981-x. Epub 2022 Oct 31.

Abstract

Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal cancer (EC) in Asia. It is a malignant digestive tract tumor with abundant gene mutations. Due to the lack of specific diagnostic markers and early cancer screening markers, most patients are diagnosed at an advanced stage. Genetic and epigenetic changes are closely related to the occurrence and development of ESCC. Here, We review the activation of proto-oncogenes into oncogenes through gene mutation and gene amplification in ESCC from a genetic and epigenetic genome perspective, We also discuss the specific regulatory mechanisms through which these oncogenes mainly affect the biological function and occurrence and development of ESCC through specific regulatory mechanisms. In addition, we summarize the clinical application value of these oncogenes is summarized, and it provides a feasible direction for clinical use as potential therapeutic and diagnostic markers.

Keywords: ESCC; Epigenetic alterations; Genetic variation; Oncogene; Signaling pathway.

Publication types

  • Review

MeSH terms

  • Cell Line, Tumor
  • Epigenesis, Genetic
  • Esophageal Neoplasms* / genetics
  • Esophageal Neoplasms* / metabolism
  • Esophageal Neoplasms* / therapy
  • Esophageal Squamous Cell Carcinoma* / genetics
  • Esophageal Squamous Cell Carcinoma* / pathology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mutation
  • Oncogenes